FIELD: pharmaceutics.
SUBSTANCE: invention relates to compounds of formula (I)
or pharmaceutically acceptable salts thereof, to pharmaceutical compositions containing them and to methods of producing said compounds.
EFFECT: novel compounds which can be used in treating conditions or diseases mediated by the P2X7 receptor are obtained.
15 cl, 1 dwg, 2 tbl, 251 ex
Title | Year | Author | Number |
---|---|---|---|
CONDENSED TRIAZOLAMINES AS P2X7 MODULATORS | 2010 |
|
RU2533122C2 |
NEW BICYCLIC COMPOUNDS OF THIOPHENYLAMIDE | 2013 |
|
RU2644565C2 |
PHENOXYMETHYL DERIVATIVES | 2016 |
|
RU2746481C1 |
HETEROARYL COMPOUNDS AS TKB INHIBITORS AND USE THEREOF | 2015 |
|
RU2742122C2 |
NOVEL HETEROARYLTRIAZOLE COMPOUNDS AS PESTICIDES | 2020 |
|
RU2824488C2 |
OXADIAZOLONE DERIVATIVES AS PPAR-DELTA AGONISTS | 2005 |
|
RU2374243C2 |
METHOD OF PREPARING BENZIMIDAZOLINONE DERIVATIVES OR SALTS THEREOF | 0 |
|
SU585811A3 |
METHOD OF THE PREPARATION OF PIPERAZINE OR PIPERIDINE DERIVATIVES OR THEIR SALTS | 0 |
|
SU683621A3 |
DERIVATIVES OF BENZODIAZEPINE, MEDICINAL AGENT COMPRISING THEREOF AND METHOD FOR THEIR PREPARING | 2000 |
|
RU2257382C2 |
DIPHENYL HETEROCYCLIC COMPOUNDS, PHARMACEUTICAL COMPOSITION BASED ON THEREOF AND METHOD OF TREATMENT | 1997 |
|
RU2175319C2 |
Authors
Dates
2022-03-25—Published
2018-05-02—Filed